2023 Duke-ISCVID Criteria for Infective Endocarditis
Updated 2023 Duke criteria incorporating CT, PET-CT, and MRI findings for IE diagnosis. Classification: Definite, Possible, or Rejected.
Score interpretation
Insufficient criteria for IE. Alternative diagnosis more likely, OR symptoms resolve with ≤4 days of antibiotics.
→ Reassess for alternative diagnoses. Repeat blood cultures if clinical suspicion persists.
1 major + 1 minor criteria, OR ≥3 minor criteria. Possible IE.
→ Continue workup. Repeat blood cultures. Echocardiography (TTE then TOE). Specialist ID/Cardiology review.
2 major OR 1 major + 3 minor OR ≥5 minor criteria. Definite IE. Also definite if pathological criteria met.
→ Commence IV antibiotics per local protocol. Cardiothoracic surgery consultation. IE MDT team activation.
Interpretation bands for the Duke-ISCVID 2023. Apply clinical judgement and local guidance.
References
- Fowler VG et al. 2023 Duke-ISCVID Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clin Infect Dis. 2023;77(4):518-526.
Related
Curated clinical cross-links plus same-class fallbacks.
- Acute Heart Failure · ESC 2021 Heart Failure Guidelines; NICE NG106
- NSTEMI / Unstable Angina · ESC 2020 NSTEMI Guidelines; NICE NG185
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
The Duke-ISCVID 2023 is covered in detail — with RCEM/NICE evidence base, indications and pitfalls — in the following exam-focused pathways on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.